Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Clinical Investigation

  • Response Monitoring in Metastatic Breast Cancer: A Prospective Study Comparing <sup>18</sup>F-FDG PET/CT with Conventional CT
    You have access
    Response Monitoring in Metastatic Breast Cancer: A Prospective Study Comparing 18F-FDG PET/CT with Conventional CT
    Marianne Vogsen, Frederik Harbo, Nick M. Jakobsen, Henriette J. Nissen, Sara E. Dahlsgaard-Wallenius, Oke Gerke, Jeanette D. Jensen, Jon T. Asmussen, Anne Marie B. Jylling, Poul-Erik Braad, Werner Vach, Marianne Ewertz and Malene G. Hildebrandt
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 355-361; DOI: https://doi.org/10.2967/jnumed.121.263358
  • A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum
    Open Access
    A Head-to-Head Comparison Between Plasma pTau181 and Tau PET Along the Alzheimer’s Disease Continuum
    Emma M. Coomans, Inge M.W. Verberk, Rik Ossenkoppele, Sander C.J. Verfaillie, Denise Visser, Mariam Gouda, Hayel Tuncel, Emma E. Wolters, Tessa Timmers, Albert D. Windhorst, Sandeep S.V. Golla, Philip Scheltens, Wiesje M. van, der Flier, Bart N.M. van Berckel and Charlotte E. Teunissen
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 437-443; DOI: https://doi.org/10.2967/jnumed.122.264279
  • <sup>68</sup>Ga-DOTA PET for Diagnosis of Spinal Cerebrospinal Fluid Leaks
    You have access
    68Ga-DOTA PET for Diagnosis of Spinal Cerebrospinal Fluid Leaks
    Petros Evangelou, Mohamed Aymen Omrane, Johannes Thurow, Michael Mix, Christian Fung, Niklas Lützen, Ganna Blazhenets, Horst Urbach, Jürgen Beck and Philipp T. Meyer
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 430-436; DOI: https://doi.org/10.2967/jnumed.122.264059
  • Exploring Vessel Wall Biology In Vivo by Ultrasensitive Total-Body PET
    You have access
    Exploring Vessel Wall Biology In Vivo by Ultrasensitive Total-Body PET
    Thorsten Derlin, Benjamin A. Spencer, Martin Mamach, Yasser Abdelhafez, Lorenzo Nardo, Ramsey D. Badawi, Simon R. Cherry and Frank M. Bengel
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 416-422; DOI: https://doi.org/10.2967/jnumed.122.264550
  • <sup>18</sup>F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus–Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002
    You have access
    18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus–Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002
    Rathan M. Subramaniam, Lyudmila DeMora, Min Yao, Sue S. Yom, Maura Gillison, Jimmy J. Caudell, John Waldron, Ping Xia, Christine H. Chung, Minh Tam Truong, Michelle Echevarria, Jason W. Chan, Jessica L. Geiger, Loren Mell, Samantha Seaward, Wade L. Thorstad, Jonathan Jay Beitler, Khalil Sultanem, Diagjin Blakaj and Quynh-Thu Le
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.122.264424
  • <sup>177</sup>Lu-PSMA-I&amp;T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
    You have access
    177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers
    Amir Karimzadeh, Matthias Heck, Robert Tauber, Karina Knorr, Bernhard Haller, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber and Isabel Rauscher
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 402-409; DOI: https://doi.org/10.2967/jnumed.122.264402
  • A Visual Interpretation Algorithm for Assessing Brain Tauopathy with <sup>18</sup>F-MK-6240 PET
    You have access
    A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18F-MK-6240 PET
    John P. Seibyl, Jonathan M. DuBois, Annie Racine, Jessica Collins, Qi Guo, Dustin Wooten, Eddie Stage, David Cheng, Roger N. Gunn, Lilly Porat, Alex Whittington, Phillip H. Kuo, Masanori Ichise, Robert Comley, Laurent Martarello and Cristian Salinas
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 444-451; DOI: https://doi.org/10.2967/jnumed.122.264371
  • You have access
    Differential Effects of Tau Stage, Lewy Body Pathology, and Substantia Nigra Degeneration on 18F-FDG PET Patterns in Clinical Alzheimer Disease
    Jesús Silva-Rodríguez, Miguel A. Labrador-Espinosa, Alexis Moscoso, Michael Schöll, Pablo Mir, Michel J. Grothe and for the Alzheimer’s Disease Neuroimaging Initiative
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 274-280; DOI: https://doi.org/10.2967/jnumed.122.264213
  • Prospective Phase II Trial of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET/CT Imaging of Integrin α<sub>v</sub>β<sub>3</sub> for Prognostication in Patients with Neuroendocrine Neoplasms
    You have access
    Prospective Phase II Trial of [68Ga]Ga-NODAGA-E[c(RGDyK)]2 PET/CT Imaging of Integrin αvβ3 for Prognostication in Patients with Neuroendocrine Neoplasms
    Esben Andreas Carlsen, Mathias Loft, Annika Loft, Dorota Czyzewska, Mikkel Andreassen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 252-259; DOI: https://doi.org/10.2967/jnumed.122.264383
  • Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease
    You have access
    Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease
    Shaney Flores, Charles D. Chen, Yi Su, Aylin Dincer, Sarah J. Keefe, Nicole S. McKay, Angela M. Paulick, Gloria Guzman Perez-Carrillo, Liang Wang, Russ C. Hornbeck, Manu Goyal, Andrei Vlassenko, Sally Schwarz, Michael L. Nickels, Dean F. Wong, Zhude Tu, Jonathan E. McConathy, John C. Morris, Tammie L.S. Benzinger and Brian A. Gordon
    Journal of Nuclear Medicine February 1, 2023, 64 (2) 287-293; DOI: https://doi.org/10.2967/jnumed.122.263948

Pages

  • Previous
  • Next
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 92
SNMMI

© 2025 SNMMI

Powered by HighWire